Mesenchymal stem cells: current clinical progress in ARDS and COVID-19Kun Xiao(Chinese PLA General Hospital), Lixin Xie(Chinese PLA General Hospital)Stem Cell Research & TherapyJuly 22, 202010.1186/s13287-020-01804-6Cited by 96SaveCiteExport RISWatch citationsRelated PapersMesenchymal stem cells reverse EMT process through blocking the activation of NF-κB and Hedgehog pathways in LPS-induced acute lung injury|Cell Death and Disease|2020|232